HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Feng-Ming Spring Kong Selected Research

Feng-Ming Spring Kong Research Topics

Disease

45Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2023 - 07/2007
29Neoplasms (Cancer)
12/2022 - 04/2006
21Lung Neoplasms (Lung Cancer)
11/2023 - 01/2005
5Neoplasm Metastasis (Metastasis)
12/2022 - 03/2012
4Lymphopenia (Lymphocytopenia)
01/2022 - 08/2021
4Breast Neoplasms (Breast Cancer)
01/2022 - 08/2021
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022 - 01/2019
3Radiation Pneumonitis
01/2021 - 01/2019
2Brain Neoplasms (Brain Tumor)
12/2022 - 01/2019
2Hepatocellular Carcinoma (Hepatoma)
01/2021 - 01/2019
2Fibrosis (Cirrhosis)
01/2020 - 11/2018
2Esophagitis
02/2018 - 01/2014
2Disease Progression
01/2018 - 10/2012
1Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
11/2023
1Pneumonia (Pneumonitis)
09/2023
1Radiation induced brachial plexopathy
01/2023
1Digestive System Neoplasms (Cancer of the Digestive System)
01/2023
1Brain Diseases (Brain Disorder)
12/2022
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022
1Heart Diseases (Heart Disease)
06/2019
1Cardiotoxicity
06/2019
1Pericardial Effusion
01/2019
1Hemorrhage
06/2014
1Chronic Obstructive Pulmonary Disease (COPD)
03/2013
1Adenocarcinoma
03/2012
1Hypoxia (Hypoxemia)
02/2012
1Anemia
07/2010
1Nasopharyngeal Carcinoma
07/2010

Drug/Important Bio-Agent (IBA)

10Biomarkers (Surrogate Marker)IBA
11/2023 - 06/2011
5CytokinesIBA
12/2022 - 01/2016
4Tyrosine Kinase InhibitorsIBA
09/2023 - 12/2017
3ErbB Receptors (EGF Receptor)IBA
09/2023 - 12/2017
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2015 - 07/2007
2B7-H1 AntigenIBA
01/2023 - 01/2021
2MicroRNAs (MicroRNA)IBA
06/2019 - 01/2016
1PlatinumIBA
11/2023
1Pentetic Acid (DTPA)FDA LinkGeneric
09/2023
1Genetic Markers (Genetic Marker)IBA
12/2022
1AnthracyclinesIBA
01/2022
1taxaneIBA
01/2022
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2021
1apatinibIBA
04/2019
1alfatide IIIBA
04/2019
1AntibodiesIBA
01/2019
1lidofenin (HIDA)IBA
11/2018
1KynurenineIBA
01/2018
1Tryptophan (L-Tryptophan)FDA Link
01/2018
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2018
1ElementsIBA
01/2018
1Immune Checkpoint InhibitorsIBA
12/2017
1Interleukin-8 (Interleukin 8)IBA
01/2017
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
02/2013
1Transforming Growth Factor beta1 (TGF beta 1)IBA
02/2013
1Tissue Plasminogen Activator (Alteplase)FDA Link
02/2013
1Fluorine-18IBA
03/2012

Therapy/Procedure

57Radiotherapy
11/2023 - 01/2005
11Therapeutics
09/2023 - 07/2007
8Drug Therapy (Chemotherapy)
01/2022 - 03/2013
2Image-Guided Radiotherapy
01/2023 - 09/2012
2Cranial Irradiation
01/2022 - 01/2019
2Adjuvant Radiotherapy
01/2022 - 08/2021
2Conformal Radiotherapy
01/2020 - 06/2013
2Radiofrequency Ablation
01/2019 - 01/2016
2Precision Medicine
12/2017 - 12/2017
1Aftercare (After-Treatment)
03/2021
1Immunotherapy
01/2021
1Proton Therapy
01/2020
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2020
1Radiation Dose Fractionation
01/2020
1Salvage Therapy
02/2019
1Re-Irradiation
07/2018
1Chemoradiotherapy
01/2016
1Complementary Therapies (Alternative Medicine)
08/2015
1Brachytherapy
09/2013
1Contraindications
03/2013
1Time-to-Treatment
10/2012
1Neoadjuvant Therapy
07/2010